Table 4.
A: Surrounding Non-Tumor Tissue Markers by Disease Type | |||||
---|---|---|---|---|---|
IBC Matched Non-Tumor Tissue (N=45) |
Treated IDC Matched Non-Tumor Tissue (N=24) |
Untreated IDC Matched Non-Tumor Tissue (N=27) |
P-Value | ||
pS6 | 0 | 7 (21.9%) | 0 | 0 | <0.0001^ |
1+ | 22 (68.8%) | 19 (82.6%) | 2 (7.4%) | ||
2+ | 3 (9.4%) | 4 (17.4%) | 25 (92.6%) | ||
3+ | 0 | 0 | 0 | ||
No normal tissue | 11 | 1 | |||
Analysis N/A | 2 | ||||
pJAK2 | 0 | 20 (60.6%) | 1 (4.2%) | 10 (52.6%) | <0.0001^ |
1+ | 10 (30.3%) | 9 (37.5%) | 9 (47.4%) | ||
2+ | 2 (6.1%) | 14 (58.3%) | 0 | ||
3+ | 1 (3.0%) | 0 | |||
No normal tissue | 9 | 8 | |||
Analysis N/A | 3 | ||||
pSTAT3 | 0 | 20 (66.7%) | 10 (45.5%) | 2 (4.3%) | <0.0001^ |
1+ | 4 (13.3%) | 11 (50%) | 12 (85.7%) | ||
2+ | 6 (20.0%) | 1 (4.6%) | 0 | ||
No normal tissue | 10 | 2 | 12 | ||
Analysis N/A | 5 | 1 | |||
IL6 | 0 | 16 (50%) | 6 (25%) | 1 (6.3%) | 0.0069^ |
1+ | 14 (43.8%) | 16 (66.7%) | 15 (93.8%) | ||
2+ | 2 (6.3%) | 2 (8.3%) | 0 | ||
No normal tissue | 10 | 10 | |||
Analysis N/A | 3 | 1 | |||
CD68* | Median (range) | 15 (0–150) | 15 (5–60) | 20 (7–40) | 0.0739^^ |
No Tumor Available | |||||
No Tissue Available | 5 | ||||
CD163* | Median (range) | 12 (2–40) | 15.5 (5–40) | 15 (4–35) | 0.1487^^ |
No Tumor Available | |||||
No Tissue Available | 4 |
B: Pairwise Comparisons of Expression Levels in Surrounding non-Tumor Tissue – P-Values (Pairwise Comparisons of Table 4A) | |||
---|---|---|---|
IBC vs Treated IDC |
IBC vs Untreated IDC |
Treated IDC vs Untreated IDC |
|
pS6^ | 0.0408 | <0.0001 | <0.0001 |
pJAK2^ | <0.0001 | 0.5383 | <0.0001 |
pSTAT3^ | <0.0001 | <0.0001 | 0.0007 |
IL6^ | 0.1580 | 0.0018 | 0.1753 |
CD68^^ | 0.1554 | 0.0294 | 0.5225 |
CD163^^ | 0.0729 | 0.1651 | 0.7318 |
Fisher's Exact Test
Kruskal-Wallis non parametric analysis of variance test
p<0.0167 is considered significant
Fisher’s Exact Test
Wilcoxon Rank Sum Test